Aurobindo Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the stock exchanges that its trading window will be closed for all designated persons including promoters, directors, KMPs, employees, and their immediate relatives starting July 1, 2025. The closure will remain in effect until 48 hours after the company declares its unaudited financial results for Q1 FY26 (quarter ending June 30, 2025). The exact date of the board meeting to approve these results will be communicated later. This is a routine compliance filing under SEBI's Insider Trading Regulations.
This is a standard regulatory disclosure and does not impact shareholders or stock price directly. However, it signals that the Q1 FY26 earnings announcement is approaching, and investors should watch for the upcoming results date.